Corpus ID: 35711135

Analysis of the S 3 and S 3 * subsite specificities of feline immunodeficiency virus ( FIV ) protease : Development of a broad-based protease inhibitor efficacious against FIV , SIV , and HIV in vitro and ex vivo

@inproceedings{Lee1998AnalysisOT,
  title={Analysis of the S 3 and S 3 * subsite specificities of feline immunodeficiency virus ( FIV ) protease : Development of a broad-based protease inhibitor efficacious against FIV , SIV , and HIV in vitro and ex vivo},
  author={T. Lee and G. Laco and B. Torbett and H. Fox and D. L. Lerner and J. Elder and C. Wong},
  year={1998}
}
  • T. Lee, G. Laco, +4 authors C. Wong
  • Published 1998
  • The S3 and S3* subsite binding specificities of HIV and feline immunodeficiency virus proteases (FIV) proteases (PRs) have been explored by using C2-symmetric competitive inhibitors. The inhibitors evaluated contained (1S, 2R, 3R, 4S)-1,4-diamino-1,4-dibenzyl-2,3-diol as P1 and P1* units, Val as P2 and P2* residues, and a variety of amino acids at the P3 and P3* positions. All inhibitors showed very high potency against HIV PR in vitro, and their Ki values ranged between 1.1 and 2.6 nM. In… CONTINUE READING
    10 Citations

    Figures and Tables from this paper

    Elucidating the inhibiting mode of AHPBA derivatives against HIV-1 protease and building predictive 3D-QSAR models.
    • 39
    • PDF
    Synthesis, screening and computational investigation of pentacycloundecane-peptoids as potent CSA-HIV PR inhibitors.
    • 18
    Structural and biochemical studies of retroviral proteases.
    • 143
    • PDF
    Peptidase inhibitors in the MEROPS database.
    • 59
    Comparing Ligand Interactions with Multiple Receptors via Serial Docking
    • 23